Overview
Combined molybdoflavoprotein enzyme deficiency involves deficiencies in enzymes dependent on molybdenum cofactor, such as sulphite oxidase, leading to metabolic disturbances and severe neurological manifestations due to toxic metabolite accumulation 2.Diagnosis
Clinical Presentation: Neurological symptoms including developmental delay, seizures, and hypotonia 2.
Imaging: Cranial ultrasound reveals rapid cerebral atrophy, calcifications, and white matter cysts; MRI/CT shows severe early brain abnormalities 2.
Laboratory Tests: Plasma analysis for vitamin C levels may indirectly indicate metabolic stress but is not specific for molybdoflavoprotein deficiency 1.Management
Supportive Care: Focus on managing symptoms and complications, including anticonvulsants for seizures 2.
Nutritional Support: Ensure adequate nutrition, though specific vitamin C supplementation is not directly indicated for this condition 1.
Monitoring: Regular cranial ultrasounds for monitoring disease progression and response to treatment 2.Special Populations
Pediatrics: Early detection and monitoring are crucial due to rapid neurological deterioration 2.Key Recommendations
Utilize cranial ultrasound for initial detection and follow-up of neurological changes in suspected cases (Evidence: Moderate 2).
Consider supportive therapies tailored to clinical manifestations, particularly seizure management (Evidence: Expert opinion 2).
Routine plasma vitamin C analysis may not be specific but can reflect overall metabolic status (Evidence: Weak 1).References
1 Robitaille L, Hoffer LJ. A simple method for plasma total vitamin C analysis suitable for routine clinical laboratory use. Nutrition journal 2016. link
2 Serrano M, Lizarraga I, Reiss J, Dias AP, Pérez-Dueñas B, Vilaseca MA et al.. Cranial ultrasound and chronological changes in molybdenum cofactor deficiency. Pediatric radiology 2007. link